nodes	percent_of_prediction	percent_of_DWPC	metapath
Regorafenib—ABCG2—Leflunomide—rheumatoid arthritis	0.0633	0.128	CbGbCtD
Regorafenib—ABCG2—Sulfasalazine—rheumatoid arthritis	0.0391	0.079	CbGbCtD
Regorafenib—ABCG2—Hydrocortisone—rheumatoid arthritis	0.0314	0.0634	CbGbCtD
Regorafenib—ABCG2—Cyclosporine—rheumatoid arthritis	0.0296	0.0599	CbGbCtD
Regorafenib—CYP2C9—Leflunomide—rheumatoid arthritis	0.0235	0.0475	CbGbCtD
Regorafenib—ABCG2—Dexamethasone—rheumatoid arthritis	0.0195	0.0394	CbGbCtD
Regorafenib—ABCB1—Methylprednisolone—rheumatoid arthritis	0.0186	0.0376	CbGbCtD
Regorafenib—CYP2C8—Hydrocortisone—rheumatoid arthritis	0.0167	0.0338	CbGbCtD
Regorafenib—CYP2C8—Cyclosporine—rheumatoid arthritis	0.0158	0.0319	CbGbCtD
Regorafenib—ABCG2—Methotrexate—rheumatoid arthritis	0.0157	0.0317	CbGbCtD
Regorafenib—CYP3A4—Ergocalciferol—rheumatoid arthritis	0.0151	0.0306	CbGbCtD
Regorafenib—CYP2C19—Prednisone—rheumatoid arthritis	0.014	0.0282	CbGbCtD
Regorafenib—CYP2B6—Dexamethasone—rheumatoid arthritis	0.0137	0.0277	CbGbCtD
Regorafenib—CYP2C19—Cyclosporine—rheumatoid arthritis	0.0132	0.0268	CbGbCtD
Regorafenib—ABCB1—Betamethasone—rheumatoid arthritis	0.0121	0.0244	CbGbCtD
Regorafenib—ABCB1—Prednisolone—rheumatoid arthritis	0.0119	0.0241	CbGbCtD
Regorafenib—ABCB1—Hydrocortisone—rheumatoid arthritis	0.0113	0.0229	CbGbCtD
Regorafenib—ABCB1—Prednisone—rheumatoid arthritis	0.0113	0.0228	CbGbCtD
Regorafenib—CYP3A4—Methylprednisolone—rheumatoid arthritis	0.0112	0.0225	CbGbCtD
Regorafenib—CYP2C9—Cyclosporine—rheumatoid arthritis	0.011	0.0223	CbGbCtD
Regorafenib—ABCB1—Cyclosporine—rheumatoid arthritis	0.0107	0.0216	CbGbCtD
Regorafenib—CYP2C8—Dexamethasone—rheumatoid arthritis	0.0104	0.021	CbGbCtD
Regorafenib—CYP2C19—Dexamethasone—rheumatoid arthritis	0.00872	0.0176	CbGbCtD
Regorafenib—CYP3A4—Triamcinolone—rheumatoid arthritis	0.00845	0.0171	CbGbCtD
Regorafenib—CYP2C9—Dexamethasone—rheumatoid arthritis	0.00725	0.0147	CbGbCtD
Regorafenib—CYP3A4—Betamethasone—rheumatoid arthritis	0.00725	0.0146	CbGbCtD
Regorafenib—CYP3A4—Prednisolone—rheumatoid arthritis	0.00715	0.0145	CbGbCtD
Regorafenib—ABCB1—Dexamethasone—rheumatoid arthritis	0.00704	0.0142	CbGbCtD
Regorafenib—CYP3A4—Hydrocortisone—rheumatoid arthritis	0.00678	0.0137	CbGbCtD
Regorafenib—CYP3A4—Prednisone—rheumatoid arthritis	0.00676	0.0136	CbGbCtD
Regorafenib—CYP3A4—Cyclosporine—rheumatoid arthritis	0.0064	0.0129	CbGbCtD
Regorafenib—ABCB1—Methotrexate—rheumatoid arthritis	0.00566	0.0114	CbGbCtD
Regorafenib—CYP3A4—Dexamethasone—rheumatoid arthritis	0.00422	0.00852	CbGbCtD
Regorafenib—FGFR2—exocrine gland—rheumatoid arthritis	0.00281	0.0363	CbGeAlD
Regorafenib—DDR2—connective tissue—rheumatoid arthritis	0.00252	0.0326	CbGeAlD
Regorafenib—FRK—lymphoid tissue—rheumatoid arthritis	0.00206	0.0266	CbGeAlD
Regorafenib—KIT—exocrine gland—rheumatoid arthritis	0.00195	0.0252	CbGeAlD
Regorafenib—EPHX2—parotid gland—rheumatoid arthritis	0.00194	0.025	CbGeAlD
Regorafenib—DDR2—lymphoid tissue—rheumatoid arthritis	0.00184	0.0238	CbGeAlD
Regorafenib—DDR2—digestive system—rheumatoid arthritis	0.00182	0.0235	CbGeAlD
Regorafenib—DDR2—tendon—rheumatoid arthritis	0.00173	0.0224	CbGeAlD
Regorafenib—EPHA2—parotid gland—rheumatoid arthritis	0.00144	0.0186	CbGeAlD
Regorafenib—FGFR2—saliva-secreting gland—rheumatoid arthritis	0.0014	0.0181	CbGeAlD
Regorafenib—EPHA2—saliva-secreting gland—rheumatoid arthritis	0.00138	0.0178	CbGeAlD
Regorafenib—FLT1—parotid gland—rheumatoid arthritis	0.00136	0.0175	CbGeAlD
Regorafenib—RET—connective tissue—rheumatoid arthritis	0.00136	0.0175	CbGeAlD
Regorafenib—RAF1—parotid gland—rheumatoid arthritis	0.00135	0.0174	CbGeAlD
Regorafenib—FLT1—saliva-secreting gland—rheumatoid arthritis	0.0013	0.0168	CbGeAlD
Regorafenib—RAF1—saliva-secreting gland—rheumatoid arthritis	0.00129	0.0167	CbGeAlD
Regorafenib—FGFR2—connective tissue—rheumatoid arthritis	0.00129	0.0167	CbGeAlD
Regorafenib—TEK—connective tissue—rheumatoid arthritis	0.00124	0.016	CbGeAlD
Regorafenib—BRAF—tendon—rheumatoid arthritis	0.00123	0.0158	CbGeAlD
Regorafenib—FLT1—connective tissue—rheumatoid arthritis	0.0012	0.0154	CbGeAlD
Regorafenib—RAF1—connective tissue—rheumatoid arthritis	0.00119	0.0153	CbGeAlD
Regorafenib—EPHX2—tendon—rheumatoid arthritis	0.00117	0.0151	CbGeAlD
Regorafenib—KDR—parotid gland—rheumatoid arthritis	0.00115	0.0148	CbGeAlD
Regorafenib—UGT1A9—digestive system—rheumatoid arthritis	0.00113	0.0145	CbGeAlD
Regorafenib—FLT4—lymphoid tissue—rheumatoid arthritis	0.00112	0.0145	CbGeAlD
Regorafenib—PDGFRA—connective tissue—rheumatoid arthritis	0.00112	0.0145	CbGeAlD
Regorafenib—KDR—saliva-secreting gland—rheumatoid arthritis	0.0011	0.0142	CbGeAlD
Regorafenib—FGFR1—tendon—rheumatoid arthritis	0.00104	0.0135	CbGeAlD
Regorafenib—KIT—parotid gland—rheumatoid arthritis	0.00102	0.0131	CbGeAlD
Regorafenib—KDR—connective tissue—rheumatoid arthritis	0.00101	0.013	CbGeAlD
Regorafenib—PDGFRB—parotid gland—rheumatoid arthritis	0.000994	0.0128	CbGeAlD
Regorafenib—RET—lymphoid tissue—rheumatoid arthritis	0.000992	0.0128	CbGeAlD
Regorafenib—RET—digestive system—rheumatoid arthritis	0.00098	0.0127	CbGeAlD
Regorafenib—KIT—saliva-secreting gland—rheumatoid arthritis	0.000974	0.0126	CbGeAlD
Regorafenib—PDGFRB—saliva-secreting gland—rheumatoid arthritis	0.000952	0.0123	CbGeAlD
Regorafenib—RET—tendon—rheumatoid arthritis	0.000933	0.012	CbGeAlD
Regorafenib—FGFR2—digestive system—rheumatoid arthritis	0.000931	0.012	CbGeAlD
Regorafenib—EPHA2—lymphoid tissue—rheumatoid arthritis	0.000926	0.012	CbGeAlD
Regorafenib—EPHA2—digestive system—rheumatoid arthritis	0.000915	0.0118	CbGeAlD
Regorafenib—TEK—lymphoid tissue—rheumatoid arthritis	0.000904	0.0117	CbGeAlD
Regorafenib—KIT—connective tissue—rheumatoid arthritis	0.000895	0.0116	CbGeAlD
Regorafenib—ABL1—parotid gland—rheumatoid arthritis	0.000886	0.0114	CbGeAlD
Regorafenib—PDGFRB—connective tissue—rheumatoid arthritis	0.000874	0.0113	CbGeAlD
Regorafenib—FLT1—lymphoid tissue—rheumatoid arthritis	0.000874	0.0113	CbGeAlD
Regorafenib—EPHA2—tendon—rheumatoid arthritis	0.000871	0.0112	CbGeAlD
Regorafenib—RAF1—lymphoid tissue—rheumatoid arthritis	0.000869	0.0112	CbGeAlD
Regorafenib—FLT1—digestive system—rheumatoid arthritis	0.000863	0.0111	CbGeAlD
Regorafenib—RAF1—digestive system—rheumatoid arthritis	0.000858	0.0111	CbGeAlD
Regorafenib—TEK—tendon—rheumatoid arthritis	0.00085	0.011	CbGeAlD
Regorafenib—ABL1—saliva-secreting gland—rheumatoid arthritis	0.000848	0.011	CbGeAlD
Regorafenib—FLT1—tendon—rheumatoid arthritis	0.000821	0.0106	CbGeAlD
Regorafenib—PDGFRA—lymphoid tissue—rheumatoid arthritis	0.000819	0.0106	CbGeAlD
Regorafenib—RAF1—tendon—rheumatoid arthritis	0.000817	0.0105	CbGeAlD
Regorafenib—PDGFRA—digestive system—rheumatoid arthritis	0.000809	0.0104	CbGeAlD
Regorafenib—ABL1—connective tissue—rheumatoid arthritis	0.000779	0.0101	CbGeAlD
Regorafenib—UGT1A1—digestive system—rheumatoid arthritis	0.000772	0.00997	CbGeAlD
Regorafenib—PDGFRA—tendon—rheumatoid arthritis	0.00077	0.00994	CbGeAlD
Regorafenib—KDR—lymphoid tissue—rheumatoid arthritis	0.000739	0.00954	CbGeAlD
Regorafenib—KDR—digestive system—rheumatoid arthritis	0.00073	0.00942	CbGeAlD
Regorafenib—KDR—tendon—rheumatoid arthritis	0.000694	0.00897	CbGeAlD
Regorafenib—KIT—lymphoid tissue—rheumatoid arthritis	0.000655	0.00845	CbGeAlD
Regorafenib—KIT—digestive system—rheumatoid arthritis	0.000647	0.00835	CbGeAlD
Regorafenib—PDGFRB—lymphoid tissue—rheumatoid arthritis	0.000639	0.00826	CbGeAlD
Regorafenib—PDGFRB—digestive system—rheumatoid arthritis	0.000632	0.00816	CbGeAlD
Regorafenib—PDGFRB—tendon—rheumatoid arthritis	0.000601	0.00776	CbGeAlD
Regorafenib—ABL1—lymphoid tissue—rheumatoid arthritis	0.00057	0.00736	CbGeAlD
Regorafenib—ABL1—digestive system—rheumatoid arthritis	0.000563	0.00727	CbGeAlD
Regorafenib—ABCG2—parotid gland—rheumatoid arthritis	0.000558	0.00721	CbGeAlD
Regorafenib—ABL1—tendon—rheumatoid arthritis	0.000536	0.00692	CbGeAlD
Regorafenib—ABCG2—saliva-secreting gland—rheumatoid arthritis	0.000535	0.00691	CbGeAlD
Regorafenib—CYP2C19—digestive system—rheumatoid arthritis	0.000418	0.0054	CbGeAlD
Regorafenib—CYP2B6—lymphoid tissue—rheumatoid arthritis	0.000332	0.00428	CbGeAlD
Regorafenib—CYP2B6—digestive system—rheumatoid arthritis	0.000327	0.00423	CbGeAlD
Regorafenib—CYP2C9—digestive system—rheumatoid arthritis	0.000324	0.00419	CbGeAlD
Regorafenib—Skin disorder—Azathioprine—rheumatoid arthritis	0.000305	0.00193	CcSEcCtD
Regorafenib—Dry mouth—Leflunomide—rheumatoid arthritis	0.000303	0.00191	CcSEcCtD
Regorafenib—Infestation NOS—Methylprednisolone—rheumatoid arthritis	0.0003	0.0019	CcSEcCtD
Regorafenib—Infestation—Methylprednisolone—rheumatoid arthritis	0.0003	0.0019	CcSEcCtD
Regorafenib—Acute coronary syndrome—Triamcinolone—rheumatoid arthritis	0.000296	0.00187	CcSEcCtD
Regorafenib—Acute coronary syndrome—Methylprednisolone—rheumatoid arthritis	0.000295	0.00187	CcSEcCtD
Regorafenib—Haemoglobin—Prednisolone—rheumatoid arthritis	0.000295	0.00186	CcSEcCtD
Regorafenib—Infection—Leflunomide—rheumatoid arthritis	0.000295	0.00186	CcSEcCtD
Regorafenib—Myocardial infarction—Triamcinolone—rheumatoid arthritis	0.000294	0.00186	CcSEcCtD
Regorafenib—Myocardial infarction—Methylprednisolone—rheumatoid arthritis	0.000294	0.00186	CcSEcCtD
Regorafenib—Haemorrhage—Prednisolone—rheumatoid arthritis	0.000293	0.00185	CcSEcCtD
Regorafenib—Angiopathy—Cyclosporine—rheumatoid arthritis	0.000292	0.00185	CcSEcCtD
Regorafenib—Nervous system disorder—Leflunomide—rheumatoid arthritis	0.000291	0.00184	CcSEcCtD
Regorafenib—Thrombocytopenia—Leflunomide—rheumatoid arthritis	0.00029	0.00184	CcSEcCtD
Regorafenib—Mediastinal disorder—Cyclosporine—rheumatoid arthritis	0.00029	0.00184	CcSEcCtD
Regorafenib—Skin disorder—Leflunomide—rheumatoid arthritis	0.000288	0.00182	CcSEcCtD
Regorafenib—Haemoglobin—Hydrocortisone—rheumatoid arthritis	0.000288	0.00182	CcSEcCtD
Regorafenib—Haemorrhage—Hydrocortisone—rheumatoid arthritis	0.000286	0.00181	CcSEcCtD
Regorafenib—Alopecia—Cyclosporine—rheumatoid arthritis	0.000285	0.0018	CcSEcCtD
Regorafenib—Dry skin—Prednisone—rheumatoid arthritis	0.000282	0.00179	CcSEcCtD
Regorafenib—Connective tissue disorder—Hydrocortisone—rheumatoid arthritis	0.000281	0.00178	CcSEcCtD
Regorafenib—Malnutrition—Cyclosporine—rheumatoid arthritis	0.00028	0.00177	CcSEcCtD
Regorafenib—Hypokalaemia—Prednisone—rheumatoid arthritis	0.00028	0.00177	CcSEcCtD
Regorafenib—Weight decreased—Dexamethasone—rheumatoid arthritis	0.000276	0.00175	CcSEcCtD
Regorafenib—Weight decreased—Betamethasone—rheumatoid arthritis	0.000276	0.00175	CcSEcCtD
Regorafenib—Alanine aminotransferase increased—Prednisone—rheumatoid arthritis	0.000272	0.00172	CcSEcCtD
Regorafenib—Gastrointestinal disorder—Azathioprine—rheumatoid arthritis	0.000271	0.00171	CcSEcCtD
Regorafenib—Haemoglobin—Triamcinolone—rheumatoid arthritis	0.000271	0.00171	CcSEcCtD
Regorafenib—Haemoglobin—Methylprednisolone—rheumatoid arthritis	0.00027	0.00171	CcSEcCtD
Regorafenib—Haemorrhage—Triamcinolone—rheumatoid arthritis	0.00027	0.00171	CcSEcCtD
Regorafenib—Haemorrhage—Methylprednisolone—rheumatoid arthritis	0.000269	0.0017	CcSEcCtD
Regorafenib—Acute coronary syndrome—Dexamethasone—rheumatoid arthritis	0.000269	0.0017	CcSEcCtD
Regorafenib—Acute coronary syndrome—Betamethasone—rheumatoid arthritis	0.000269	0.0017	CcSEcCtD
Regorafenib—Myocardial infarction—Dexamethasone—rheumatoid arthritis	0.000267	0.00169	CcSEcCtD
Regorafenib—Myocardial infarction—Betamethasone—rheumatoid arthritis	0.000267	0.00169	CcSEcCtD
Regorafenib—Connective tissue disorder—Methylprednisolone—rheumatoid arthritis	0.000264	0.00167	CcSEcCtD
Regorafenib—Tremor—Cyclosporine—rheumatoid arthritis	0.000263	0.00166	CcSEcCtD
Regorafenib—Anaemia—Cyclosporine—rheumatoid arthritis	0.000259	0.00164	CcSEcCtD
Regorafenib—Decreased appetite—Leflunomide—rheumatoid arthritis	0.000258	0.00163	CcSEcCtD
Regorafenib—Gastrointestinal pain—Azathioprine—rheumatoid arthritis	0.000257	0.00162	CcSEcCtD
Regorafenib—Gastrointestinal disorder—Leflunomide—rheumatoid arthritis	0.000256	0.00162	CcSEcCtD
Regorafenib—Fatigue—Leflunomide—rheumatoid arthritis	0.000256	0.00162	CcSEcCtD
Regorafenib—Pain—Leflunomide—rheumatoid arthritis	0.000254	0.0016	CcSEcCtD
Regorafenib—Leukopenia—Cyclosporine—rheumatoid arthritis	0.000251	0.00159	CcSEcCtD
Regorafenib—Cardiac disorder—Methylprednisolone—rheumatoid arthritis	0.00025	0.00158	CcSEcCtD
Regorafenib—Malnutrition—Hydrocortisone—rheumatoid arthritis	0.000249	0.00158	CcSEcCtD
Regorafenib—Neutropenia—Prednisone—rheumatoid arthritis	0.000249	0.00157	CcSEcCtD
Regorafenib—Abdominal pain—Azathioprine—rheumatoid arthritis	0.000248	0.00157	CcSEcCtD
Regorafenib—Body temperature increased—Azathioprine—rheumatoid arthritis	0.000248	0.00157	CcSEcCtD
Regorafenib—CYP3A4—digestive system—rheumatoid arthritis	0.000247	0.00319	CbGeAlD
Regorafenib—Haemoglobin—Dexamethasone—rheumatoid arthritis	0.000246	0.00155	CcSEcCtD
Regorafenib—Haemoglobin—Betamethasone—rheumatoid arthritis	0.000246	0.00155	CcSEcCtD
Regorafenib—Haemorrhage—Dexamethasone—rheumatoid arthritis	0.000245	0.00155	CcSEcCtD
Regorafenib—Haemorrhage—Betamethasone—rheumatoid arthritis	0.000245	0.00155	CcSEcCtD
Regorafenib—Angiopathy—Methylprednisolone—rheumatoid arthritis	0.000244	0.00154	CcSEcCtD
Regorafenib—Gastrointestinal pain—Leflunomide—rheumatoid arthritis	0.000243	0.00153	CcSEcCtD
Regorafenib—Mediastinal disorder—Methylprednisolone—rheumatoid arthritis	0.000242	0.00153	CcSEcCtD
Regorafenib—Hypertension—Cyclosporine—rheumatoid arthritis	0.000242	0.00153	CcSEcCtD
Regorafenib—Weight decreased—Prednisone—rheumatoid arthritis	0.000241	0.00152	CcSEcCtD
Regorafenib—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—rheumatoid arthritis	0.000237	0.0015	CcSEcCtD
Regorafenib—Body temperature increased—Leflunomide—rheumatoid arthritis	0.000234	0.00148	CcSEcCtD
Regorafenib—Abdominal pain—Leflunomide—rheumatoid arthritis	0.000234	0.00148	CcSEcCtD
Regorafenib—Malnutrition—Methylprednisolone—rheumatoid arthritis	0.000234	0.00148	CcSEcCtD
Regorafenib—Acute coronary syndrome—Prednisone—rheumatoid arthritis	0.000234	0.00148	CcSEcCtD
Regorafenib—Dry mouth—Cyclosporine—rheumatoid arthritis	0.000234	0.00148	CcSEcCtD
Regorafenib—Myocardial infarction—Prednisone—rheumatoid arthritis	0.000233	0.00147	CcSEcCtD
Regorafenib—Toxic epidermal necrolysis—Methotrexate—rheumatoid arthritis	0.000232	0.00147	CcSEcCtD
Regorafenib—Infection—Cyclosporine—rheumatoid arthritis	0.000227	0.00144	CcSEcCtD
Regorafenib—Nervous system disorder—Cyclosporine—rheumatoid arthritis	0.000224	0.00142	CcSEcCtD
Regorafenib—Thrombocytopenia—Cyclosporine—rheumatoid arthritis	0.000224	0.00142	CcSEcCtD
Regorafenib—Skin disorder—Cyclosporine—rheumatoid arthritis	0.000222	0.00141	CcSEcCtD
Regorafenib—Angiopathy—Dexamethasone—rheumatoid arthritis	0.000222	0.0014	CcSEcCtD
Regorafenib—Angiopathy—Betamethasone—rheumatoid arthritis	0.000222	0.0014	CcSEcCtD
Regorafenib—Hypertension—Prednisolone—rheumatoid arthritis	0.00022	0.00139	CcSEcCtD
Regorafenib—Alopecia—Dexamethasone—rheumatoid arthritis	0.000216	0.00137	CcSEcCtD
Regorafenib—Alopecia—Betamethasone—rheumatoid arthritis	0.000216	0.00137	CcSEcCtD
Regorafenib—Hypertension—Hydrocortisone—rheumatoid arthritis	0.000215	0.00136	CcSEcCtD
Regorafenib—Diarrhoea—Azathioprine—rheumatoid arthritis	0.000215	0.00136	CcSEcCtD
Regorafenib—Haemoglobin—Prednisone—rheumatoid arthritis	0.000214	0.00135	CcSEcCtD
Regorafenib—Haemorrhage—Prednisone—rheumatoid arthritis	0.000213	0.00135	CcSEcCtD
Regorafenib—Asthenia—Leflunomide—rheumatoid arthritis	0.000213	0.00135	CcSEcCtD
Regorafenib—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—rheumatoid arthritis	0.000211	0.00133	CcSEcCtD
Regorafenib—Connective tissue disorder—Prednisone—rheumatoid arthritis	0.000209	0.00132	CcSEcCtD
Regorafenib—Neutropenia—Methotrexate—rheumatoid arthritis	0.000208	0.00132	CcSEcCtD
Regorafenib—Diarrhoea—Leflunomide—rheumatoid arthritis	0.000203	0.00128	CcSEcCtD
Regorafenib—Hypertension—Triamcinolone—rheumatoid arthritis	0.000203	0.00128	CcSEcCtD
Regorafenib—Hypertension—Methylprednisolone—rheumatoid arthritis	0.000202	0.00128	CcSEcCtD
Regorafenib—Infection—Hydrocortisone—rheumatoid arthritis	0.000202	0.00128	CcSEcCtD
Regorafenib—Vomiting—Azathioprine—rheumatoid arthritis	0.0002	0.00126	CcSEcCtD
Regorafenib—Nervous system disorder—Hydrocortisone—rheumatoid arthritis	0.000199	0.00126	CcSEcCtD
Regorafenib—Decreased appetite—Cyclosporine—rheumatoid arthritis	0.000199	0.00126	CcSEcCtD
Regorafenib—Infestation NOS—Methotrexate—rheumatoid arthritis	0.000198	0.00125	CcSEcCtD
Regorafenib—Infestation—Methotrexate—rheumatoid arthritis	0.000198	0.00125	CcSEcCtD
Regorafenib—Rash—Azathioprine—rheumatoid arthritis	0.000198	0.00125	CcSEcCtD
Regorafenib—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—rheumatoid arthritis	0.000198	0.00125	CcSEcCtD
Regorafenib—Dermatitis—Azathioprine—rheumatoid arthritis	0.000198	0.00125	CcSEcCtD
Regorafenib—Gastrointestinal disorder—Cyclosporine—rheumatoid arthritis	0.000198	0.00125	CcSEcCtD
Regorafenib—Skin disorder—Hydrocortisone—rheumatoid arthritis	0.000198	0.00125	CcSEcCtD
Regorafenib—Fatigue—Cyclosporine—rheumatoid arthritis	0.000197	0.00125	CcSEcCtD
Regorafenib—Headache—Azathioprine—rheumatoid arthritis	0.000197	0.00124	CcSEcCtD
Regorafenib—Stevens-Johnson syndrome—Methotrexate—rheumatoid arthritis	0.000197	0.00124	CcSEcCtD
Regorafenib—Pain—Cyclosporine—rheumatoid arthritis	0.000196	0.00124	CcSEcCtD
Regorafenib—Dry mouth—Triamcinolone—rheumatoid arthritis	0.000195	0.00124	CcSEcCtD
Regorafenib—Stomatitis—Methotrexate—rheumatoid arthritis	0.000193	0.00122	CcSEcCtD
Regorafenib—Angiopathy—Prednisone—rheumatoid arthritis	0.000193	0.00122	CcSEcCtD
Regorafenib—Infection—Triamcinolone—rheumatoid arthritis	0.00019	0.0012	CcSEcCtD
Regorafenib—Infection—Methylprednisolone—rheumatoid arthritis	0.00019	0.0012	CcSEcCtD
Regorafenib—Vomiting—Leflunomide—rheumatoid arthritis	0.000189	0.00119	CcSEcCtD
Regorafenib—Alopecia—Prednisone—rheumatoid arthritis	0.000188	0.00119	CcSEcCtD
Regorafenib—Hepatobiliary disease—Methotrexate—rheumatoid arthritis	0.000188	0.00119	CcSEcCtD
Regorafenib—Nervous system disorder—Methylprednisolone—rheumatoid arthritis	0.000187	0.00119	CcSEcCtD
Regorafenib—Gastrointestinal pain—Cyclosporine—rheumatoid arthritis	0.000187	0.00118	CcSEcCtD
Regorafenib—Rash—Leflunomide—rheumatoid arthritis	0.000187	0.00118	CcSEcCtD
Regorafenib—Dermatitis—Leflunomide—rheumatoid arthritis	0.000187	0.00118	CcSEcCtD
Regorafenib—Nausea—Azathioprine—rheumatoid arthritis	0.000187	0.00118	CcSEcCtD
Regorafenib—Headache—Leflunomide—rheumatoid arthritis	0.000186	0.00118	CcSEcCtD
Regorafenib—Skin disorder—Methylprednisolone—rheumatoid arthritis	0.000186	0.00117	CcSEcCtD
Regorafenib—Malnutrition—Prednisone—rheumatoid arthritis	0.000185	0.00117	CcSEcCtD
Regorafenib—Hypertension—Dexamethasone—rheumatoid arthritis	0.000184	0.00116	CcSEcCtD
Regorafenib—Hypertension—Betamethasone—rheumatoid arthritis	0.000184	0.00116	CcSEcCtD
Regorafenib—Abdominal pain—Cyclosporine—rheumatoid arthritis	0.000181	0.00114	CcSEcCtD
Regorafenib—Body temperature increased—Cyclosporine—rheumatoid arthritis	0.000181	0.00114	CcSEcCtD
Regorafenib—Haemoglobin—Methotrexate—rheumatoid arthritis	0.000179	0.00113	CcSEcCtD
Regorafenib—Pain—Prednisolone—rheumatoid arthritis	0.000178	0.00113	CcSEcCtD
Regorafenib—Haemorrhage—Methotrexate—rheumatoid arthritis	0.000178	0.00113	CcSEcCtD
Regorafenib—ABCB1—lymphoid tissue—rheumatoid arthritis	0.000177	0.00229	CbGeAlD
Regorafenib—Decreased appetite—Hydrocortisone—rheumatoid arthritis	0.000177	0.00112	CcSEcCtD
Regorafenib—Nausea—Leflunomide—rheumatoid arthritis	0.000176	0.00111	CcSEcCtD
Regorafenib—Urinary tract disorder—Methotrexate—rheumatoid arthritis	0.000176	0.00111	CcSEcCtD
Regorafenib—Gastrointestinal disorder—Hydrocortisone—rheumatoid arthritis	0.000176	0.00111	CcSEcCtD
Regorafenib—Fatigue—Hydrocortisone—rheumatoid arthritis	0.000175	0.00111	CcSEcCtD
Regorafenib—ABCB1—digestive system—rheumatoid arthritis	0.000175	0.00226	CbGeAlD
Regorafenib—Urethral disorder—Methotrexate—rheumatoid arthritis	0.000175	0.0011	CcSEcCtD
Regorafenib—Pain—Hydrocortisone—rheumatoid arthritis	0.000174	0.0011	CcSEcCtD
Regorafenib—Infection—Dexamethasone—rheumatoid arthritis	0.000173	0.00109	CcSEcCtD
Regorafenib—Infection—Betamethasone—rheumatoid arthritis	0.000173	0.00109	CcSEcCtD
Regorafenib—Anaemia—Prednisone—rheumatoid arthritis	0.000171	0.00108	CcSEcCtD
Regorafenib—Nervous system disorder—Dexamethasone—rheumatoid arthritis	0.00017	0.00108	CcSEcCtD
Regorafenib—Nervous system disorder—Betamethasone—rheumatoid arthritis	0.00017	0.00108	CcSEcCtD
Regorafenib—Thrombocytopenia—Dexamethasone—rheumatoid arthritis	0.00017	0.00108	CcSEcCtD
Regorafenib—Thrombocytopenia—Betamethasone—rheumatoid arthritis	0.00017	0.00108	CcSEcCtD
Regorafenib—Erythema multiforme—Methotrexate—rheumatoid arthritis	0.000168	0.00106	CcSEcCtD
Regorafenib—Gastrointestinal pain—Hydrocortisone—rheumatoid arthritis	0.000166	0.00105	CcSEcCtD
Regorafenib—Cardiac disorder—Methotrexate—rheumatoid arthritis	0.000165	0.00104	CcSEcCtD
Regorafenib—Fatigue—Triamcinolone—rheumatoid arthritis	0.000165	0.00104	CcSEcCtD
Regorafenib—Fatigue—Methylprednisolone—rheumatoid arthritis	0.000165	0.00104	CcSEcCtD
Regorafenib—Asthenia—Cyclosporine—rheumatoid arthritis	0.000164	0.00104	CcSEcCtD
Regorafenib—Pain—Triamcinolone—rheumatoid arthritis	0.000164	0.00104	CcSEcCtD
Regorafenib—Angiopathy—Methotrexate—rheumatoid arthritis	0.000162	0.00102	CcSEcCtD
Regorafenib—Abdominal pain—Hydrocortisone—rheumatoid arthritis	0.000161	0.00102	CcSEcCtD
Regorafenib—Body temperature increased—Hydrocortisone—rheumatoid arthritis	0.000161	0.00102	CcSEcCtD
Regorafenib—Mediastinal disorder—Methotrexate—rheumatoid arthritis	0.00016	0.00101	CcSEcCtD
Regorafenib—Hypertension—Prednisone—rheumatoid arthritis	0.00016	0.00101	CcSEcCtD
Regorafenib—Alopecia—Methotrexate—rheumatoid arthritis	0.000157	0.000995	CcSEcCtD
Regorafenib—Unspecified disorder of skin and subcutaneous tissue—Prednisone—rheumatoid arthritis	0.000157	0.000992	CcSEcCtD
Regorafenib—Diarrhoea—Cyclosporine—rheumatoid arthritis	0.000157	0.00099	CcSEcCtD
Regorafenib—Gastrointestinal pain—Methylprednisolone—rheumatoid arthritis	0.000156	0.000988	CcSEcCtD
Regorafenib—Malnutrition—Methotrexate—rheumatoid arthritis	0.000155	0.00098	CcSEcCtD
Regorafenib—Body temperature increased—Triamcinolone—rheumatoid arthritis	0.000151	0.000958	CcSEcCtD
Regorafenib—Abdominal pain—Methylprednisolone—rheumatoid arthritis	0.000151	0.000955	CcSEcCtD
Regorafenib—Decreased appetite—Dexamethasone—rheumatoid arthritis	0.000151	0.000955	CcSEcCtD
Regorafenib—Decreased appetite—Betamethasone—rheumatoid arthritis	0.000151	0.000955	CcSEcCtD
Regorafenib—Infection—Prednisone—rheumatoid arthritis	0.00015	0.000951	CcSEcCtD
Regorafenib—Gastrointestinal disorder—Dexamethasone—rheumatoid arthritis	0.00015	0.000949	CcSEcCtD
Regorafenib—Gastrointestinal disorder—Betamethasone—rheumatoid arthritis	0.00015	0.000949	CcSEcCtD
Regorafenib—Fatigue—Dexamethasone—rheumatoid arthritis	0.00015	0.000948	CcSEcCtD
Regorafenib—Fatigue—Betamethasone—rheumatoid arthritis	0.00015	0.000948	CcSEcCtD
Regorafenib—Pain—Dexamethasone—rheumatoid arthritis	0.000149	0.00094	CcSEcCtD
Regorafenib—Pain—Betamethasone—rheumatoid arthritis	0.000149	0.00094	CcSEcCtD
Regorafenib—Nervous system disorder—Prednisone—rheumatoid arthritis	0.000148	0.000939	CcSEcCtD
Regorafenib—Skin disorder—Prednisone—rheumatoid arthritis	0.000147	0.00093	CcSEcCtD
Regorafenib—Asthenia—Hydrocortisone—rheumatoid arthritis	0.000146	0.000923	CcSEcCtD
Regorafenib—Vomiting—Cyclosporine—rheumatoid arthritis	0.000146	0.00092	CcSEcCtD
Regorafenib—Rash—Cyclosporine—rheumatoid arthritis	0.000144	0.000913	CcSEcCtD
Regorafenib—Dermatitis—Cyclosporine—rheumatoid arthritis	0.000144	0.000912	CcSEcCtD
Regorafenib—Headache—Cyclosporine—rheumatoid arthritis	0.000143	0.000907	CcSEcCtD
Regorafenib—Anaemia—Methotrexate—rheumatoid arthritis	0.000143	0.000906	CcSEcCtD
Regorafenib—Gastrointestinal pain—Dexamethasone—rheumatoid arthritis	0.000142	0.000899	CcSEcCtD
Regorafenib—Gastrointestinal pain—Betamethasone—rheumatoid arthritis	0.000142	0.000899	CcSEcCtD
Regorafenib—Diarrhoea—Hydrocortisone—rheumatoid arthritis	0.000139	0.00088	CcSEcCtD
Regorafenib—Leukopenia—Methotrexate—rheumatoid arthritis	0.000139	0.000877	CcSEcCtD
Regorafenib—Asthenia—Triamcinolone—rheumatoid arthritis	0.000137	0.000869	CcSEcCtD
Regorafenib—Abdominal pain—Dexamethasone—rheumatoid arthritis	0.000137	0.000869	CcSEcCtD
Regorafenib—Abdominal pain—Betamethasone—rheumatoid arthritis	0.000137	0.000869	CcSEcCtD
Regorafenib—Body temperature increased—Betamethasone—rheumatoid arthritis	0.000137	0.000869	CcSEcCtD
Regorafenib—Body temperature increased—Dexamethasone—rheumatoid arthritis	0.000137	0.000869	CcSEcCtD
Regorafenib—Asthenia—Methylprednisolone—rheumatoid arthritis	0.000137	0.000867	CcSEcCtD
Regorafenib—Nausea—Cyclosporine—rheumatoid arthritis	0.000136	0.00086	CcSEcCtD
Regorafenib—Decreased appetite—Prednisone—rheumatoid arthritis	0.000132	0.000832	CcSEcCtD
Regorafenib—Rash—Prednisolone—rheumatoid arthritis	0.000131	0.000831	CcSEcCtD
Regorafenib—Dermatitis—Prednisolone—rheumatoid arthritis	0.000131	0.00083	CcSEcCtD
Regorafenib—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—rheumatoid arthritis	0.000131	0.000829	CcSEcCtD
Regorafenib—Diarrhoea—Methylprednisolone—rheumatoid arthritis	0.000131	0.000827	CcSEcCtD
Regorafenib—Fatigue—Prednisone—rheumatoid arthritis	0.00013	0.000825	CcSEcCtD
Regorafenib—Headache—Prednisolone—rheumatoid arthritis	0.00013	0.000825	CcSEcCtD
Regorafenib—Vomiting—Hydrocortisone—rheumatoid arthritis	0.000129	0.000818	CcSEcCtD
Regorafenib—Rash—Hydrocortisone—rheumatoid arthritis	0.000128	0.000811	CcSEcCtD
Regorafenib—Dermatitis—Hydrocortisone—rheumatoid arthritis	0.000128	0.00081	CcSEcCtD
Regorafenib—Headache—Hydrocortisone—rheumatoid arthritis	0.000127	0.000806	CcSEcCtD
Regorafenib—Infection—Methotrexate—rheumatoid arthritis	0.000126	0.000795	CcSEcCtD
Regorafenib—Asthenia—Betamethasone—rheumatoid arthritis	0.000125	0.000789	CcSEcCtD
Regorafenib—Asthenia—Dexamethasone—rheumatoid arthritis	0.000125	0.000789	CcSEcCtD
Regorafenib—Nervous system disorder—Methotrexate—rheumatoid arthritis	0.000124	0.000784	CcSEcCtD
Regorafenib—Thrombocytopenia—Methotrexate—rheumatoid arthritis	0.000124	0.000783	CcSEcCtD
Regorafenib—Gastrointestinal pain—Prednisone—rheumatoid arthritis	0.000124	0.000783	CcSEcCtD
Regorafenib—Nausea—Prednisolone—rheumatoid arthritis	0.000124	0.000782	CcSEcCtD
Regorafenib—Skin disorder—Methotrexate—rheumatoid arthritis	0.000123	0.000777	CcSEcCtD
Regorafenib—Vomiting—Triamcinolone—rheumatoid arthritis	0.000122	0.00077	CcSEcCtD
Regorafenib—Vomiting—Methylprednisolone—rheumatoid arthritis	0.000122	0.000768	CcSEcCtD
Regorafenib—Nausea—Hydrocortisone—rheumatoid arthritis	0.000121	0.000764	CcSEcCtD
Regorafenib—Rash—Triamcinolone—rheumatoid arthritis	0.000121	0.000764	CcSEcCtD
Regorafenib—Dermatitis—Triamcinolone—rheumatoid arthritis	0.000121	0.000763	CcSEcCtD
Regorafenib—Rash—Methylprednisolone—rheumatoid arthritis	0.000121	0.000762	CcSEcCtD
Regorafenib—Dermatitis—Methylprednisolone—rheumatoid arthritis	0.00012	0.000761	CcSEcCtD
Regorafenib—Headache—Triamcinolone—rheumatoid arthritis	0.00012	0.000759	CcSEcCtD
Regorafenib—Headache—Methylprednisolone—rheumatoid arthritis	0.00012	0.000757	CcSEcCtD
Regorafenib—Abdominal pain—Prednisone—rheumatoid arthritis	0.00012	0.000757	CcSEcCtD
Regorafenib—Body temperature increased—Prednisone—rheumatoid arthritis	0.00012	0.000757	CcSEcCtD
Regorafenib—Diarrhoea—Betamethasone—rheumatoid arthritis	0.000119	0.000752	CcSEcCtD
Regorafenib—Diarrhoea—Dexamethasone—rheumatoid arthritis	0.000119	0.000752	CcSEcCtD
Regorafenib—Nausea—Triamcinolone—rheumatoid arthritis	0.000114	0.00072	CcSEcCtD
Regorafenib—Nausea—Methylprednisolone—rheumatoid arthritis	0.000114	0.000718	CcSEcCtD
Regorafenib—Vomiting—Dexamethasone—rheumatoid arthritis	0.000111	0.000699	CcSEcCtD
Regorafenib—Vomiting—Betamethasone—rheumatoid arthritis	0.000111	0.000699	CcSEcCtD
Regorafenib—Decreased appetite—Methotrexate—rheumatoid arthritis	0.00011	0.000695	CcSEcCtD
Regorafenib—Rash—Dexamethasone—rheumatoid arthritis	0.00011	0.000693	CcSEcCtD
Regorafenib—Rash—Betamethasone—rheumatoid arthritis	0.00011	0.000693	CcSEcCtD
Regorafenib—Dermatitis—Dexamethasone—rheumatoid arthritis	0.000109	0.000692	CcSEcCtD
Regorafenib—Dermatitis—Betamethasone—rheumatoid arthritis	0.000109	0.000692	CcSEcCtD
Regorafenib—Gastrointestinal disorder—Methotrexate—rheumatoid arthritis	0.000109	0.000691	CcSEcCtD
Regorafenib—Fatigue—Methotrexate—rheumatoid arthritis	0.000109	0.00069	CcSEcCtD
Regorafenib—Headache—Dexamethasone—rheumatoid arthritis	0.000109	0.000689	CcSEcCtD
Regorafenib—Headache—Betamethasone—rheumatoid arthritis	0.000109	0.000689	CcSEcCtD
Regorafenib—Asthenia—Prednisone—rheumatoid arthritis	0.000109	0.000687	CcSEcCtD
Regorafenib—Pain—Methotrexate—rheumatoid arthritis	0.000108	0.000684	CcSEcCtD
Regorafenib—Diarrhoea—Prednisone—rheumatoid arthritis	0.000104	0.000655	CcSEcCtD
Regorafenib—Gastrointestinal pain—Methotrexate—rheumatoid arthritis	0.000103	0.000654	CcSEcCtD
Regorafenib—Nausea—Betamethasone—rheumatoid arthritis	0.000103	0.000653	CcSEcCtD
Regorafenib—Nausea—Dexamethasone—rheumatoid arthritis	0.000103	0.000653	CcSEcCtD
Regorafenib—Body temperature increased—Methotrexate—rheumatoid arthritis	0.0001	0.000632	CcSEcCtD
Regorafenib—Abdominal pain—Methotrexate—rheumatoid arthritis	0.0001	0.000632	CcSEcCtD
Regorafenib—Vomiting—Prednisone—rheumatoid arthritis	9.62e-05	0.000609	CcSEcCtD
Regorafenib—Rash—Prednisone—rheumatoid arthritis	9.54e-05	0.000604	CcSEcCtD
Regorafenib—Dermatitis—Prednisone—rheumatoid arthritis	9.53e-05	0.000603	CcSEcCtD
Regorafenib—Headache—Prednisone—rheumatoid arthritis	9.48e-05	0.0006	CcSEcCtD
Regorafenib—Asthenia—Methotrexate—rheumatoid arthritis	9.08e-05	0.000574	CcSEcCtD
Regorafenib—Nausea—Prednisone—rheumatoid arthritis	8.99e-05	0.000569	CcSEcCtD
Regorafenib—Diarrhoea—Methotrexate—rheumatoid arthritis	8.65e-05	0.000547	CcSEcCtD
Regorafenib—Vomiting—Methotrexate—rheumatoid arthritis	8.04e-05	0.000509	CcSEcCtD
Regorafenib—Rash—Methotrexate—rheumatoid arthritis	7.98e-05	0.000504	CcSEcCtD
Regorafenib—Dermatitis—Methotrexate—rheumatoid arthritis	7.97e-05	0.000504	CcSEcCtD
Regorafenib—Headache—Methotrexate—rheumatoid arthritis	7.92e-05	0.000501	CcSEcCtD
Regorafenib—Nausea—Methotrexate—rheumatoid arthritis	7.51e-05	0.000475	CcSEcCtD
Regorafenib—KDR—Signaling Pathways—CXCL8—rheumatoid arthritis	4.2e-06	1.56e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—MAPK8—rheumatoid arthritis	4.2e-06	1.56e-05	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—CCL2—rheumatoid arthritis	4.2e-06	1.56e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—CD80—rheumatoid arthritis	4.2e-06	1.56e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling by GPCR—CXCL8—rheumatoid arthritis	4.19e-06	1.56e-05	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—IL6R—rheumatoid arthritis	4.18e-06	1.55e-05	CbGpPWpGaD
Regorafenib—RAF1—Developmental Biology—IL6—rheumatoid arthritis	4.18e-06	1.55e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—LEP—rheumatoid arthritis	4.18e-06	1.55e-05	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—MTHFR—rheumatoid arthritis	4.18e-06	1.55e-05	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	4.15e-06	1.54e-05	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—TYK2—rheumatoid arthritis	4.15e-06	1.54e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Innate Immune System—IL6—rheumatoid arthritis	4.15e-06	1.54e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—IL1B—rheumatoid arthritis	4.12e-06	1.53e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—CD4—rheumatoid arthritis	4.12e-06	1.53e-05	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—CCL2—rheumatoid arthritis	4.12e-06	1.53e-05	CbGpPWpGaD
Regorafenib—RAF1—Immune System—IFNG—rheumatoid arthritis	4.12e-06	1.53e-05	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—TYK2—rheumatoid arthritis	4.11e-06	1.53e-05	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—IL6R—rheumatoid arthritis	4.11e-06	1.53e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—IL2—rheumatoid arthritis	4.11e-06	1.52e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—CCR5—rheumatoid arthritis	4.1e-06	1.52e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—PTGS2—rheumatoid arthritis	4.09e-06	1.52e-05	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—NOS3—rheumatoid arthritis	4.07e-06	1.51e-05	CbGpPWpGaD
Regorafenib—RAF1—Disease—TYK2—rheumatoid arthritis	4.06e-06	1.51e-05	CbGpPWpGaD
Regorafenib—ABL1—Innate Immune System—IL6—rheumatoid arthritis	4.04e-06	1.5e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—IL2RA—rheumatoid arthritis	4.04e-06	1.5e-05	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—NOS3—rheumatoid arthritis	4.04e-06	1.5e-05	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—MMP9—rheumatoid arthritis	4.02e-06	1.49e-05	CbGpPWpGaD
Regorafenib—ABL1—Immune System—IL1B—rheumatoid arthritis	4.02e-06	1.49e-05	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—IL2—rheumatoid arthritis	4.02e-06	1.49e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling by GPCR—IL2—rheumatoid arthritis	4.01e-06	1.49e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—C3—rheumatoid arthritis	4e-06	1.49e-05	CbGpPWpGaD
Regorafenib—ABL1—Immune System—IL2—rheumatoid arthritis	4e-06	1.49e-05	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—POMC—rheumatoid arthritis	4e-06	1.48e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—POMC—rheumatoid arthritis	3.99e-06	1.48e-05	CbGpPWpGaD
Regorafenib—RAF1—Disease—NOS3—rheumatoid arthritis	3.99e-06	1.48e-05	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—NFKB1—rheumatoid arthritis	3.98e-06	1.48e-05	CbGpPWpGaD
Regorafenib—RAF1—Immune System—CD4—rheumatoid arthritis	3.98e-06	1.48e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—FN1—rheumatoid arthritis	3.94e-06	1.46e-05	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—POMC—rheumatoid arthritis	3.94e-06	1.46e-05	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—POMC—rheumatoid arthritis	3.94e-06	1.46e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—IL6ST—rheumatoid arthritis	3.93e-06	1.46e-05	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—MAPK8—rheumatoid arthritis	3.91e-06	1.45e-05	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—CCL2—rheumatoid arthritis	3.91e-06	1.45e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—CCL2—rheumatoid arthritis	3.9e-06	1.45e-05	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—IL6R—rheumatoid arthritis	3.9e-06	1.45e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—IL6R—rheumatoid arthritis	3.89e-06	1.44e-05	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—TP53—rheumatoid arthritis	3.88e-06	1.44e-05	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—ENO1—rheumatoid arthritis	3.85e-06	1.43e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—NFKB1—rheumatoid arthritis	3.85e-06	1.43e-05	CbGpPWpGaD
Regorafenib—BRAF—Disease—TGFB1—rheumatoid arthritis	3.81e-06	1.41e-05	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—TYK2—rheumatoid arthritis	3.81e-06	1.41e-05	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—MMP9—rheumatoid arthritis	3.8e-06	1.41e-05	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	3.79e-06	1.41e-05	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	3.79e-06	1.41e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—MAPK8—rheumatoid arthritis	3.78e-06	1.4e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—CD80—rheumatoid arthritis	3.78e-06	1.4e-05	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—NFKB1—rheumatoid arthritis	3.76e-06	1.4e-05	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—ENO1—rheumatoid arthritis	3.76e-06	1.39e-05	CbGpPWpGaD
Regorafenib—ABL1—Immune System—NFKB1—rheumatoid arthritis	3.75e-06	1.39e-05	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—TYK2—rheumatoid arthritis	3.74e-06	1.39e-05	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—NOS3—rheumatoid arthritis	3.74e-06	1.39e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—LEP—rheumatoid arthritis	3.73e-06	1.38e-05	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	3.71e-06	1.38e-05	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—MAPK8—rheumatoid arthritis	3.7e-06	1.37e-05	CbGpPWpGaD
Regorafenib—RAF1—Innate Immune System—IL6—rheumatoid arthritis	3.69e-06	1.37e-05	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—MED1—rheumatoid arthritis	3.69e-06	1.37e-05	CbGpPWpGaD
Regorafenib—ABL1—Immune System—MAPK8—rheumatoid arthritis	3.68e-06	1.37e-05	CbGpPWpGaD
Regorafenib—RAF1—Immune System—IL1B—rheumatoid arthritis	3.67e-06	1.36e-05	CbGpPWpGaD
Regorafenib—RAF1—Disease—CD4—rheumatoid arthritis	3.67e-06	1.36e-05	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—NOS3—rheumatoid arthritis	3.67e-06	1.36e-05	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—CAT—rheumatoid arthritis	3.67e-06	1.36e-05	CbGpPWpGaD
Regorafenib—RAF1—Immune System—IL2—rheumatoid arthritis	3.66e-06	1.36e-05	CbGpPWpGaD
Regorafenib—RAF1—Disease—PTGS2—rheumatoid arthritis	3.65e-06	1.35e-05	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—CXCL8—rheumatoid arthritis	3.61e-06	1.34e-05	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—VEGFA—rheumatoid arthritis	3.61e-06	1.34e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—POMC—rheumatoid arthritis	3.59e-06	1.33e-05	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—ALB—rheumatoid arthritis	3.59e-06	1.33e-05	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—ALB—rheumatoid arthritis	3.59e-06	1.33e-05	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—CXCL8—rheumatoid arthritis	3.58e-06	1.33e-05	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—TYK2—rheumatoid arthritis	3.55e-06	1.32e-05	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—IL6—rheumatoid arthritis	3.55e-06	1.32e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—TYK2—rheumatoid arthritis	3.54e-06	1.31e-05	CbGpPWpGaD
Regorafenib—FGFR2—Disease—TGFB1—rheumatoid arthritis	3.53e-06	1.31e-05	CbGpPWpGaD
Regorafenib—ABCB1—Transmembrane transport of small molecules—ALB—rheumatoid arthritis	3.51e-06	1.3e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—FN1—rheumatoid arthritis	3.51e-06	1.3e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—CCL2—rheumatoid arthritis	3.51e-06	1.3e-05	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—ENO1—rheumatoid arthritis	3.51e-06	1.3e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—IL6R—rheumatoid arthritis	3.5e-06	1.3e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—IL6ST—rheumatoid arthritis	3.5e-06	1.3e-05	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—NOS3—rheumatoid arthritis	3.49e-06	1.29e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—NOS3—rheumatoid arthritis	3.48e-06	1.29e-05	CbGpPWpGaD
Regorafenib—KIT—Disease—TGFB1—rheumatoid arthritis	3.47e-06	1.29e-05	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—IL2—rheumatoid arthritis	3.45e-06	1.28e-05	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	3.45e-06	1.28e-05	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—NOS3—rheumatoid arthritis	3.43e-06	1.27e-05	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—NOS3—rheumatoid arthritis	3.43e-06	1.27e-05	CbGpPWpGaD
Regorafenib—RAF1—Immune System—NFKB1—rheumatoid arthritis	3.43e-06	1.27e-05	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—ACP5—rheumatoid arthritis	3.43e-06	1.27e-05	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—B3GNT2—rheumatoid arthritis	3.43e-06	1.27e-05	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—IL2—rheumatoid arthritis	3.42e-06	1.27e-05	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—VEGFA—rheumatoid arthritis	3.41e-06	1.27e-05	CbGpPWpGaD
Regorafenib—RAF1—Immune System—MAPK8—rheumatoid arthritis	3.37e-06	1.25e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—CD80—rheumatoid arthritis	3.37e-06	1.25e-05	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—POMC—rheumatoid arthritis	3.34e-06	1.24e-05	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—CXCL8—rheumatoid arthritis	3.32e-06	1.23e-05	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—TGFB1—rheumatoid arthritis	3.32e-06	1.23e-05	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	3.31e-06	1.23e-05	CbGpPWpGaD
Regorafenib—FGFR1—Disease—TGFB1—rheumatoid arthritis	3.29e-06	1.22e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Disease—TGFB1—rheumatoid arthritis	3.28e-06	1.22e-05	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—MMP9—rheumatoid arthritis	3.27e-06	1.21e-05	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—CXCL8—rheumatoid arthritis	3.26e-06	1.21e-05	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—MMP9—rheumatoid arthritis	3.24e-06	1.2e-05	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—NFKB1—rheumatoid arthritis	3.23e-06	1.2e-05	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—NFKB1—rheumatoid arthritis	3.2e-06	1.19e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—POMC—rheumatoid arthritis	3.2e-06	1.19e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—TYK2—rheumatoid arthritis	3.19e-06	1.18e-05	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—MAPK8—rheumatoid arthritis	3.18e-06	1.18e-05	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—IL2—rheumatoid arthritis	3.17e-06	1.18e-05	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—MAPK8—rheumatoid arthritis	3.15e-06	1.17e-05	CbGpPWpGaD
Regorafenib—MAPK11—Immune System—IL6—rheumatoid arthritis	3.14e-06	1.17e-05	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—PTGS2—rheumatoid arthritis	3.14e-06	1.17e-05	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—PTGS2—rheumatoid arthritis	3.14e-06	1.17e-05	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—TGFB1—rheumatoid arthritis	3.13e-06	1.16e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—NOS3—rheumatoid arthritis	3.13e-06	1.16e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—CCL2—rheumatoid arthritis	3.13e-06	1.16e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—IL6R—rheumatoid arthritis	3.12e-06	1.16e-05	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—IL2—rheumatoid arthritis	3.11e-06	1.16e-05	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—CAT—rheumatoid arthritis	3.11e-06	1.15e-05	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—CXCL8—rheumatoid arthritis	3.09e-06	1.15e-05	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—BGN—rheumatoid arthritis	3.09e-06	1.15e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—CXCL8—rheumatoid arthritis	3.08e-06	1.14e-05	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—MTHFR—rheumatoid arthritis	3.06e-06	1.14e-05	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—ALB—rheumatoid arthritis	3.04e-06	1.13e-05	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	3.02e-06	1.12e-05	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—MMP9—rheumatoid arthritis	3e-06	1.11e-05	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—NFKB1—rheumatoid arthritis	2.97e-06	1.1e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—TGFB1—rheumatoid arthritis	2.96e-06	1.1e-05	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—IL2—rheumatoid arthritis	2.96e-06	1.1e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—IL2—rheumatoid arthritis	2.95e-06	1.09e-05	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—MMP9—rheumatoid arthritis	2.95e-06	1.09e-05	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—VEGFA—rheumatoid arthritis	2.94e-06	1.09e-05	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—MAPK8—rheumatoid arthritis	2.92e-06	1.08e-05	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—NFKB1—rheumatoid arthritis	2.92e-06	1.08e-05	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—NOS3—rheumatoid arthritis	2.91e-06	1.08e-05	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—VEGFA—rheumatoid arthritis	2.91e-06	1.08e-05	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—IL6—rheumatoid arthritis	2.88e-06	1.07e-05	CbGpPWpGaD
Regorafenib—BRAF—Disease—IL6—rheumatoid arthritis	2.87e-06	1.07e-05	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—MAPK8—rheumatoid arthritis	2.87e-06	1.06e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—TYK2—rheumatoid arthritis	2.84e-06	1.06e-05	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—ALOX5—rheumatoid arthritis	2.84e-06	1.05e-05	CbGpPWpGaD
Regorafenib—KIT—Immune System—IL6—rheumatoid arthritis	2.83e-06	1.05e-05	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—MMP9—rheumatoid arthritis	2.8e-06	1.04e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—NOS3—rheumatoid arthritis	2.79e-06	1.04e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—MMP9—rheumatoid arthritis	2.79e-06	1.04e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—CXCL8—rheumatoid arthritis	2.78e-06	1.03e-05	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—CAT—rheumatoid arthritis	2.77e-06	1.03e-05	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—NFKB1—rheumatoid arthritis	2.77e-06	1.03e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—NFKB1—rheumatoid arthritis	2.76e-06	1.02e-05	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—TP53—rheumatoid arthritis	2.73e-06	1.01e-05	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—MAPK8—rheumatoid arthritis	2.72e-06	1.01e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—MAPK8—rheumatoid arthritis	2.71e-06	1.01e-05	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—CAT—rheumatoid arthritis	2.71e-06	1e-05	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—VEGFA—rheumatoid arthritis	2.69e-06	1e-05	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—TGFB1—rheumatoid arthritis	2.69e-06	1e-05	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—IL6—rheumatoid arthritis	2.69e-06	9.97e-06	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—IL6—rheumatoid arthritis	2.68e-06	9.95e-06	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—TGFB1—rheumatoid arthritis	2.67e-06	9.9e-06	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—PTGS2—rheumatoid arthritis	2.66e-06	9.89e-06	CbGpPWpGaD
Regorafenib—FGFR2—Disease—IL6—rheumatoid arthritis	2.66e-06	9.88e-06	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—IL2—rheumatoid arthritis	2.66e-06	9.86e-06	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—VEGFA—rheumatoid arthritis	2.65e-06	9.82e-06	CbGpPWpGaD
Regorafenib—RAF1—Disease—TGFB1—rheumatoid arthritis	2.64e-06	9.79e-06	CbGpPWpGaD
Regorafenib—KIT—Disease—IL6—rheumatoid arthritis	2.61e-06	9.7e-06	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—MTHFR—rheumatoid arthritis	2.59e-06	9.62e-06	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—TP53—rheumatoid arthritis	2.58e-06	9.57e-06	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—CAT—rheumatoid arthritis	2.53e-06	9.38e-06	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—MMP9—rheumatoid arthritis	2.51e-06	9.33e-06	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—VEGFA—rheumatoid arthritis	2.51e-06	9.32e-06	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—VEGFA—rheumatoid arthritis	2.51e-06	9.3e-06	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—IL6—rheumatoid arthritis	2.5e-06	9.27e-06	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—NFKB1—rheumatoid arthritis	2.49e-06	9.23e-06	CbGpPWpGaD
Regorafenib—FGFR1—Disease—IL6—rheumatoid arthritis	2.48e-06	9.21e-06	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—CXCL8—rheumatoid arthritis	2.48e-06	9.19e-06	CbGpPWpGaD
Regorafenib—PDGFRA—Disease—IL6—rheumatoid arthritis	2.47e-06	9.18e-06	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—TGFB1—rheumatoid arthritis	2.47e-06	9.18e-06	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—POMC—rheumatoid arthritis	2.45e-06	9.09e-06	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—MAPK8—rheumatoid arthritis	2.44e-06	9.07e-06	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—TGFB1—rheumatoid arthritis	2.43e-06	9.02e-06	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—IL6—rheumatoid arthritis	2.41e-06	8.96e-06	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—IL2—rheumatoid arthritis	2.37e-06	8.79e-06	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—IL6—rheumatoid arthritis	2.36e-06	8.76e-06	CbGpPWpGaD
Regorafenib—RAF1—Signaling by GPCR—IL6—rheumatoid arthritis	2.36e-06	8.74e-06	CbGpPWpGaD
Regorafenib—ABL1—Immune System—IL6—rheumatoid arthritis	2.35e-06	8.73e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—ENO1—rheumatoid arthritis	2.32e-06	8.59e-06	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—MTHFR—rheumatoid arthritis	2.31e-06	8.59e-06	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—TGFB1—rheumatoid arthritis	2.31e-06	8.56e-06	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—TGFB1—rheumatoid arthritis	2.3e-06	8.53e-06	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—MTHFR—rheumatoid arthritis	2.26e-06	8.38e-06	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—VEGFA—rheumatoid arthritis	2.26e-06	8.38e-06	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—MMP9—rheumatoid arthritis	2.24e-06	8.31e-06	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—ALB—rheumatoid arthritis	2.23e-06	8.28e-06	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—IL6—rheumatoid arthritis	2.23e-06	8.27e-06	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—TP53—rheumatoid arthritis	2.22e-06	8.23e-06	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—NFKB1—rheumatoid arthritis	2.22e-06	8.23e-06	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—TP53—rheumatoid arthritis	2.2e-06	8.15e-06	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—MAPK8—rheumatoid arthritis	2.18e-06	8.09e-06	CbGpPWpGaD
Regorafenib—RAF1—Immune System—IL6—rheumatoid arthritis	2.15e-06	7.99e-06	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—NOS3—rheumatoid arthritis	2.14e-06	7.92e-06	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—MTHFR—rheumatoid arthritis	2.11e-06	7.83e-06	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—POMC—rheumatoid arthritis	2.07e-06	7.69e-06	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—TGFB1—rheumatoid arthritis	2.07e-06	7.69e-06	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—TP53—rheumatoid arthritis	2.04e-06	7.56e-06	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—IL6—rheumatoid arthritis	2.03e-06	7.53e-06	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—VEGFA—rheumatoid arthritis	2.01e-06	7.47e-06	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—IL6—rheumatoid arthritis	2.01e-06	7.46e-06	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—TP53—rheumatoid arthritis	2e-06	7.42e-06	CbGpPWpGaD
Regorafenib—RAF1—Disease—IL6—rheumatoid arthritis	1.99e-06	7.37e-06	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—PTGS2—rheumatoid arthritis	1.95e-06	7.25e-06	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—TP53—rheumatoid arthritis	1.9e-06	7.04e-06	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—TP53—rheumatoid arthritis	1.89e-06	7.03e-06	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—ALB—rheumatoid arthritis	1.89e-06	7.01e-06	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—IL6—rheumatoid arthritis	1.86e-06	6.92e-06	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—POMC—rheumatoid arthritis	1.85e-06	6.87e-06	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—TGFB1—rheumatoid arthritis	1.85e-06	6.85e-06	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—IL6—rheumatoid arthritis	1.83e-06	6.79e-06	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—NOS3—rheumatoid arthritis	1.81e-06	6.71e-06	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—POMC—rheumatoid arthritis	1.81e-06	6.7e-06	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—IL6—rheumatoid arthritis	1.74e-06	6.45e-06	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—IL6—rheumatoid arthritis	1.73e-06	6.43e-06	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—TP53—rheumatoid arthritis	1.71e-06	6.33e-06	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—POMC—rheumatoid arthritis	1.69e-06	6.26e-06	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—ALB—rheumatoid arthritis	1.69e-06	6.26e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—CAT—rheumatoid arthritis	1.67e-06	6.19e-06	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—PTGS2—rheumatoid arthritis	1.65e-06	6.14e-06	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—ALB—rheumatoid arthritis	1.65e-06	6.11e-06	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—NOS3—rheumatoid arthritis	1.61e-06	5.99e-06	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—NOS3—rheumatoid arthritis	1.57e-06	5.84e-06	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—IL6—rheumatoid arthritis	1.56e-06	5.79e-06	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—ALB—rheumatoid arthritis	1.54e-06	5.71e-06	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—TP53—rheumatoid arthritis	1.52e-06	5.64e-06	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—PTGS2—rheumatoid arthritis	1.48e-06	5.48e-06	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—NOS3—rheumatoid arthritis	1.47e-06	5.46e-06	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—PTGS2—rheumatoid arthritis	1.44e-06	5.35e-06	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—IL6—rheumatoid arthritis	1.39e-06	5.16e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—MTHFR—rheumatoid arthritis	1.39e-06	5.16e-06	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—PTGS2—rheumatoid arthritis	1.35e-06	4.99e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—POMC—rheumatoid arthritis	1.11e-06	4.13e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—ALB—rheumatoid arthritis	1.01e-06	3.76e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—NOS3—rheumatoid arthritis	9.7e-07	3.6e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—PTGS2—rheumatoid arthritis	8.87e-07	3.29e-06	CbGpPWpGaD
